Pharmaceuticals News

Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.

HealthCarePoint Completes the Integration of Transnational Collaborative Platform for Healthcare and Clinical Research

Connecting HealthCare and Clinical Research - January 08, 2013 - HealthCarePoint

Wescadia Group’s BioDeal 360™: Analysis of Deal Activity in the Australian Life Science Sector

Wescadia Group, a healthcare consultancy firm, announces the release of its report “BioDeal 360™”. The report provides strategic analysis, commentary, insight, and opinion on selected deals in the Australian life science industry in 2012. - December 19, 2012 - Wescadia Group Pty Ltd

2012 - An Award-Winning Year for SFL

This year, SFL’s multifunctional expertise has been independently recognised through two important business awards. In July, Shayesteh Fürst-Ladani, Managing Director of the company, received the Open University Business School’s Alumni Award Outstanding Contribution to an... - December 19, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd

Pharma SFE: Translating Strategy Into Action

This two-day conference will focus on how organizations need to focus on translating their strategy into action, discuss real life case studies from top experts in the pharma industry which include the top 50 companies and major players and champions of Pharma industry. They will discuss the importance behind establishing and implementing a successful sales force model to better understand and respond to ever-changing customer needs. - December 16, 2012 - American Leaders

ICRC-Weyer Clinical CRO Looks Back at a Successful Year 2012

ICRC-Weyer GmbH, a clinical contract research organization (CRO) based in Berlin, Germany, has released its review of the year 2012, stating it has been a successful and exciting 12 months for everybody involved in the business. The company looks forward to more constructive partnerships and growth for the year ahead. - December 16, 2012 - ICRC-Weyer GmbH

Bashanda A. Peay, CPHT Recognized by Strathmore's Who's Who Worldwide Publication

Bashanda A. Peay, CPHT Recognized by Strathmore's Who's Who Worldwide Publication

Bashanda A. Peay, CPHT of Chesapeake, Virginia has been included in the Strathmore’s Who’s Who Worldwide Edition for her outstanding contributions and achievements in the field of government healthcare. About Bashanda A. Peay, CPHT Ms. Peay has over 6 years experience in the field of... - December 07, 2012 - Strathmore Worldwide

Sentrx Business Development Team Expands

Sentrx continues to add to its Business Development staff by hiring three new outstanding solution oriented individuals. - December 07, 2012 - Sentrx

Wright & McGurk Announces New Campaign to Help Actos® Patients Diagnosed with Bladder Cancer

Wright McGurk is reaching out to consumers who have developed bladder cancer after taking their prescription diabetes medicine, Actos®. Injured patients are encouraged to call Wright McGurk today. - December 06, 2012 - Wright & McGurk

Topix Pharmaceuticals, Inc. Offers a Comprehensive Professional Peel System That Consists of Two Chemical Peels: Intermediate and Advanced with Different Acid

Topix Pharmaceuticals, Inc. Offers a Comprehensive Professional Peel System That Consists of Two Chemical Peels: Intermediate and Advanced with Different Acid

Replenix® MD Perfect 10 Peels (“The peel”) – medical grade, in-office aesthetic treatments designed to provide maximum, predictable and noticeable. These peels contain a synergistic blend of ingredients that visibly reduce the signs of aging with one peel session. - December 04, 2012 - Topix Pharmaceuticals, Inc.

Mevesi Now in Partnership with EPIC Pharmacies

Business Intelligence Provider Collaborates with Major Buying Group. - November 28, 2012 - Mevesi, Inc.

GlaxoSmithKline Honors Institute for Safe Families with $40,000 IMPACT Award

Philadelphia Nonprofit to Receive $40,000 in Funding for Providing Innovative Access to Healthcare - November 15, 2012 - GlaxoSmithKline

New Video Illustrates the Benefits of AdvantaFlex(R) BioPharmaceutical TPE Tubing; Shows Viewers the Tubing’s Versatility

AdvantaPure(R) has released a new video that details the benefits and uses of its biopharmaceutical grade TPE tubing, AdvantaFlex. The flexible, translucent tubing may be sterile welded, heat sealed, and molded into fittings. It is also an excellent choice for peristaltic pumps as it eliminates silicone tubing splices. The video illustrates all of these, points out the tubing’s extensive testing, and notes its suitability for pharmaceutical and biotech applications. - November 15, 2012 - NewAge Industries, Inc.

Dr. Toufigh Gordi to Discuss the Selection of Appropriate Mathematical Modeling Techniques in Drug Development at 4th World PK/PD Summit

Dr. Gordi, will discuss choice of models and their Impact in the Drug Development Process on November 28, 2012 in Frankfort, Germany. - November 08, 2012 - Rosa & Co LLC

2nd International Conference on Translational Medicine

OMICS Group, the World class Open Access Publisher and Scientific Events Organizer is proud to announce 2nd International Conference on Translational Medicine to be held during August 5-7, 2013 in Chicago-North Shore, USA. Translational Medicine-2013 will bring together representatives from the pharma, government and leading academic research institutions. Together they will share cutting-edge and will discuss on advancement of early stage research to clinical treatments. - November 02, 2012 - OMICS Group Incorporation

International Summit on Clinical Pharmacy & Dispensing

International Summit on Clinical Pharmacy & Dispensing which is going to be held during Nov 18-20, 2013 at San Antonio, Texas, USA. - November 02, 2012 - OMICS Group Incorporation

Wright & McGurk Law Offering Free GranuFlo® Case Evaluation for Injured Dialysis Patients

Wright & McGurk Law Offering Free GranuFlo® Case Evaluation for Injured Dialysis Patients

Wright & McGurk Law is offering a free case evaluation for patients or their loved ones who have been injured by their dialysis treatment. A recent FDA recall could be behind these injuries. - October 25, 2012 - Wright & McGurk

Sentrx Welcomes Addition of New Team Leads

Sentrx introduces four new healthcare professionals to handle growth in adverse event management. - October 25, 2012 - Sentrx

Cen-Med Enterprises Celebrates 20 Years in Business

Cen-Med Enterprises Celebrates 20 Years in Business

Cen-Med is celebrating 20 years in the healthcare distribution and services business this year, at their national headquarters located in New Brunswick, NJ. - October 22, 2012 - Cen-Med Enterprises

BDA Advises ICICI Venture on Sale of Radiant Research to Kinderhook's CRA

Business Development Asia LLC ("BDA") is pleased to report that its client Radiant Research, Inc. (“Radiant”) has been acquired by CRA Holdings, Inc (“CRA”), a portfolio company of New York-based private equity firm Kinderhook Industries, LLC... - October 22, 2012 - BDA Partners Ltd

Validated Sterile Single Use Manifold Assemblies Now Available from AdvantaPure(R); Sterilized Parts Save Pharmaceutical Manufacturers Labor & Time

High purity tubing manufacturer AdvantaPure now offers single use molded manifold assemblies that are validated as sterile. This eases the procurement process for pharmaceutical and biopharm companies who use them; customers can now order assemblies that are ready for installation upon receipt. Assemblies made from silicone or AdvantaFlex TPE are gamma irradiated for a sterility assurance level of 10-6. Third-party testing, performed on a regular basis, ensures validation. - October 19, 2012 - NewAge Industries, Inc.

VersaSuite Receives CCHIT Clinical Research Certification

VersaSuite Receives CCHIT Clinical Research Certification

VersaSuite 8.0 is the first ever product to receive CCHIT’s add-on Clinical Research Certification. - October 16, 2012 - VersaSuite

New Jersey Law Firm Assists Victims During Fungal Meningitis Outbreak From Tainted Epidural Steroid Injections

New Jersey Law Firm Assists Victims During Fungal Meningitis Outbreak From Tainted Epidural Steroid Injections

New Jersey personal injury lawyer Scott Grossman is currently investigating the current Fungal Meningitis outbreak in New Jersey and in several other states and is making himself available to victims for consultation. The United States Centers for Disease Control and Prevention (CDC) announced that... - October 15, 2012 - The Grossman Law Firm, LLC

New Omega-3 Structure Function Claim for DHA-Rich Algae Oil

New Omega-3 Structure Function Claim for DHA-Rich Algae Oil

Source-Omega today forwarded new structure function claims for dietary omega-3 intake from a single algae oil. Both omega-3 docosahexaenoic acid (DHA) and omega-3 eicosapentaenoic acid (EPA) are present in their oil. As a supplier, the company has defined DHA-rich algae oil uses in very low density... - October 11, 2012 - Source-Omega

Dr. Pratap Singh, to Discuss PK/PD Modeling Analysis of a Compound Targeting Muscle Growth in Rosa’s Impact Webinar Series

Dr. Singh, will present “Role of Myostatin in Muscle Growth: Key Learnings From PK/PD Modeling Analysis” Webinar October 17, 2012. - October 10, 2012 - Rosa & Co LLC

Dr Emil Haldey to Discuss Compounding in the Modern Dermatology Practice at the Mount Sinai Medical Center, October 18, 2012

Dr Emil J. Haldey will speak about history, rationale, and benefits of compounding for modern dermatology practice at the Mount Sinai Medical Center. Dr Haldey continuously researches the field and will discuss the most relevant topics. - October 10, 2012 - Emilior Pharmaceutical Compounding

Results of Type C Guidance Meeting with Food & Drug Administration (FDA) of ZYDIS® ODT Fluoxetine in the Treatment of Repetitive Behaviors in Autism

Results of Type C Guidance Meeting with Food & Drug Administration (FDA) of ZYDIS® ODT Fluoxetine in the Treatment of Repetitive Behaviors in Autism

Autism Therapeutics LLC ("Autism Therapeutics") announced today that the Type C Guidance Meeting with FDA to discuss the ZYDIS® ODT Fluoxetine / Autism program has taken place. The FDA and Autism Therapeutics discussed the completion of the Phase III development of the program... - October 09, 2012 - Autism Therapeutics LLC

90 People Sickened with Meningitis from Tainted Epidural Pain Shots

The victims of contaminated epidural shots who have contracted meningitis have legal rights. Bagolie Friedman Injury Lawyers is ready to answer any questions the public may have related to these potential claims. As always the consultations are free and confidential. - October 09, 2012 - Bagolie Friedman Injury Lawyers

"Sandoz Will be the Leading Biosimilar Drug Company in 2012, with Revenue of $308 Million" Predicts New Visiongain Report

A new report by Visiongain predicts that Sandoz will retain its position as the global leader in the biosimilar drugs market in 2012. In that year, its three follow-on biologics will achieve $308m in revenue. Combined revenue for the top three companies in that market will grow with a CAGR of close to 25% between 2011 and 2016. Those findings, and others, appear in Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2012-2022, published in 1st October 2012. - October 07, 2012 - visiongain

Diabecline Antibiotic Receives Drug Store News Award

Diabecline® first aid antibiotic, offered by pharmaCline®, has been named the winner of the Drug Store News Best New Product award. This recognition was by vote of key pharmacy industry decision makers at the ECRM® Marketgate™ 2012 meetings held in Charlotte, N.C. Drug Store News... - October 05, 2012 - pharmaCline

IonSense® Introduces the OpenSpot Quick Strips™ for the DART OS Transmission Module™, Providing Rapid Analysis in Food Safety and Product Quality

IonSense® Introduces the OpenSpot Quick Strips™ for the DART OS Transmission Module™, Providing Rapid Analysis in Food Safety and Product Quality

New Product to be exhibited at the AOAC International Annual Meeting and Exposition in Las Vegas, NV October 1 through October 4, 2012 - October 01, 2012 - IonSense, Inc.

IonSense, Inc. Issued Two Patents on Direct Analysis in Real Time Mass Spectrometry.  Introduces New Product at International Mass Spectrometry Conference, Kyoto, Japan.

IonSense, Inc. Issued Two Patents on Direct Analysis in Real Time Mass Spectrometry. Introduces New Product at International Mass Spectrometry Conference, Kyoto, Japan.

New DART-OS Source Demonstrated Live to Meeting Attendees, Highlighting Applications in Food Safety and Forensics. - September 27, 2012 - IonSense, Inc.

Pharma Anti- Counterfeiting 2012 by Virtue Insight Ltd on 18th October 2012, UK

Virtue Insight Ltd is pleased to announce “Pharma Anti- Counterfeiting 2012 – Competences to Combat Counterfeits in EU & USA” on 18th October 2012 at Marriott Marble Arch Hotel, London, UK. Visit: http://www.virtueinsight.com/pharma/Pharma-Anti-Counterfeiting-2012/ This... - September 21, 2012 - Virtue Insight

Source-Omega Claims JAMA Meta-Study Unethical; Calls for Ban of the Word Omega-3 on Drug Labels

Source-Omega Claims JAMA Meta-Study Unethical; Calls for Ban of the Word Omega-3 on Drug Labels

Source-Omega says the Food and Drug Administration may need to ban the use of the word omega-3 on all drug labels and descriptions. That is, if omega-3 is only a food word. This is at issue because the company says the September 12th JAMA study also misleads those benefiting from current... - September 20, 2012 - Source-Omega

Ameridose Sponsors Health Connect Partners' 2012 Fall Hospital Pharmacy Conference

Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to announce its sponsorship of Health Connect Partners’ 2012 Fall Hospital Pharmacy Conference, September 24-26 at the Hyatt Regency in Dallas, Texas. - September 19, 2012 - Ameridose, LLC

The Boulder Group Publishes Net Lease Drug Store Market Research Report

The Boulder Group Publishes Net Lease Drug Store Market Research Report

Net lease drug store cap rates compressed across the board - September 15, 2012 - The Boulder Group

pharmaCline Announces Poster Presentation at the Symposium for the Advancement of Wound Care Fall 2012

The poster entitled, “Multi-case Human Field Studies of Diabetic Foot Injuries Treated with Tetracycline delivered by SSPT™: A Novel Delivery System Yields Effective Results” is authored by Dr. Christopher Ayo Otiko, DPM, and features three unique clinical case studies. - September 13, 2012 - pharmaCline

"Pharma Lyophilisation Market Will Reach $2.48 Billion in 2012" Predicts Visiongain Report

A new report by visiongain predicts that the 2012 world market for lyophilisation (freeze drying) products and services for pharma will reach $2.48 billion. That revenue forecast and others appear in Lyophilisation for Pharmaceuticals: Products and Services Market 2012-2022, published in September 2012. Visiongain is a business information provider based in London, UK. - September 13, 2012 - visiongain

New Visiongain Report Shows Commercial Prospects for the 20 Leading Biopharmaceutical Companies

A new report by visiongain assesses prospects for the leading 20 biopharma companies worldwide. Top pharmaceutical companies have consolidated their hold on the market by buying up most of the leading biotech products and platforms, according to Pharma Leader Series: Top 20 Biological Drug Manufacturers 2012-2022, published in September 2012. - September 13, 2012 - visiongain

"Painkillers Market Will Reach $61.6 Billion in 2012" Visiongain Report Predicts

A new report by visiongain predicts that the world market for drugs to relieve pain will reach $61.6 billion for 2012. That revenue forecast appears in World Pain Relieving Drug Market 2012-2022, published in September 2012. Visiongain is a business information provider based in London, UK. - September 13, 2012 - visiongain

Sentrx Unveils New, User-Friendly Website

Sentrx introduces a new and improved website located at www.Sentrx.com. - September 12, 2012 - Sentrx

"Pharmaceutical Contract Manufacturing Market Will Reach $47.6 Billion in 2012" Predicts Visiongain Report

A new report by visiongain predicts that the world market for pharmaceutical contract manufacturing will be worth $47.6 billion in 2012. Between 2011 and 2016, the overall market will grow with a compound annual growth rate (CAGR) of over 6%. Demand for outsourcing will increase worldwide, driving revenue growth. Those findings and others appear in Pharmaceutical Contract Manufacturing: World Market Outlook 2012-2022, published in August 2012. - September 11, 2012 - visiongain

Breakout Discussion Groups Announced at CHI's Immunogenicity Summit 2012 in Bethesda, MD, Oct. 10-12

Delegates now have the option to choose from 10 moderated breakout discussion groups at this industry leading event facilitated by FDA and industry and academic experts. - September 11, 2012 - Cambridge Healthtech Institute

Dr. Malcolm Rowland, to Discuss Physiologically-Based Pharmacokinetics in Rosa’s Impact Webinar Series

Dr. Rowland, will present “Drug development and physiologically based pharmacokinetics” Webinar September 19, 2012. - September 08, 2012 - Rosa & Co LLC

Speed Script and RxMedic Combine Pharmacy Management System with Automated Dispensing

Speed Script and RxMedic team up to offer a pharmacy management system that integrates the latest pharmacy robot with software that verifies filled prescriptions and completes other tasks. This equipment helps improve workflow management at a small or large pharmacy. - September 08, 2012 - RxMedic

MedPro Rx, Inc. Ranked Second Among Triangle Top Small Businesses by Business Leader Magazine

Local Specialty Infusion Pharmacy Takes Second Place in Small Business Competition - August 31, 2012 - MedPro Rx, Inc.

GlaxoSmithKline and Rosa Present Psoriasis Collaboration Results at 17th International IRA Conference

PhysioPD™ modeling collaboration in psoriasis to be presented September 9-13, 2012. - August 14, 2012 - Rosa & Co LLC

VIRUN® Closes $2.1 Million Series-A Funding to Bolster Innovation and World-Wide Expansion

VIRUN® Closes $2.1 Million Series-A Funding to Bolster Innovation and World-Wide Expansion

After almost 10 years of self-funding growth and business expansion, VIRUN is ready to further-illuminate its presence and capitalize on its patented technology portfolio and product development. - August 02, 2012 - VIRUN

Rosa to Present Mechanistic Systems Pharmacology Workshop at 2012 ICSB Conference

Workshop focused on Rosa’s Model Qualification Method to be held August 19th, Toronto, Canada. - August 02, 2012 - Rosa & Co LLC

Drug Risk/Benefit Analysis; Sentrx Comments New E.U. Regulations

Sentrx, industry leader in providing outsourced drug safety solutions, comprehensive pharmacovigilance solutions and data management services, comments on new E.U. Regulations. - August 02, 2012 - Sentrx

"Vaccines Market Will Reach $33.8 Billion in 2012" Visiongain Report Predicts

A new report by visiongain predicts that the 2012 world market for vaccines to treat human beings will reach $33.8 billion. That revenue forecast appears in World Vaccines Market 2012-2022, published in July 2012. Visiongain is a business information provider based in London, UK. - July 27, 2012 - visiongain

Press Releases 1,701 - 1,750 of 2,701